BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28750923)

  • 1. Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells.
    Caslin HL; McLeod JJA; Spence AJ; Qayum AA; Kolawole EM; Taruselli MT; Paranjape A; Elford HL; Ryan JJ
    Cell Immunol; 2017 Sep; 319():10-16. PubMed ID: 28750923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription.
    McLeod JJA; Caslin HL; Spence AJ; Kolawole EM; Qayum AA; Paranjape A; Taruselli M; Haque TT; Kiwanuka KN; Elford HL; Ryan JJ
    Cell Immunol; 2017 Dec; 322():41-48. PubMed ID: 28964543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9.
    Stassen M; Müller C; Arnold M; Hültner L; Klein-Hessling S; Neudörfl C; Reineke T; Serfling E; Schmitt E
    J Immunol; 2001 Apr; 166(7):4391-8. PubMed ID: 11254693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity.
    Paranjape A; Chernushevich O; Qayum AA; Spence AJ; Taruselli MT; Abebayehu D; Barnstein BO; McLeod JJ; Baker B; Bajaj GS; Chumanevich AP; Oskeritzian CA; Ryan JJ
    J Leukoc Biol; 2016 Dec; 100(6):1395-1404. PubMed ID: 27443878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1 Suppresses IL-33-Induced Mast Cell Function.
    Ndaw VS; Abebayehu D; Spence AJ; Paez PA; Kolawole EM; Taruselli MT; Caslin HL; Chumanevich AP; Paranjape A; Baker B; Barnstein BO; Haque TT; Kiwanuka KN; Oskeritzian CA; Ryan JJ
    J Immunol; 2017 Aug; 199(3):866-873. PubMed ID: 28637902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.
    Lee SA; Fitzgerald SM; Huang SK; Li C; Chi DS; Milhorn DM; Krishnaswamy G
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):283-91. PubMed ID: 15191916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain.
    Wilbers RHP; van Raaij DR; Westerhof LB; Bakker J; Smant G; Schots A
    PLoS One; 2017; 12(10):e0186317. PubMed ID: 29016674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saucerneol F inhibits tumor necrosis factor-α and IL-6 production by suppressing Fyn-mediated pathways in FcεRI-mediated mast cells.
    Lu Y; Piao D; Zhang H; Li X; Chao GH; Park SJ; Chang YC; Kim CH; Murakami M; Jung SH; Choi JH; Son JK; Chang HW
    Food Chem Toxicol; 2013 Sep; 59():696-702. PubMed ID: 23851146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells.
    Chiba N; Masuda A; Yoshikai Y; Matsuguchi T
    J Cell Physiol; 2007 Oct; 213(1):126-36. PubMed ID: 17458900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effect of Poncirus trifoliata fruit through inhibition of NF-kappaB activation in mast cells.
    Shin TY; Oh JM; Choi BJ; Park WH; Kim CH; Jun CD; Kim SH
    Toxicol In Vitro; 2006 Oct; 20(7):1071-6. PubMed ID: 16574371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
    Ho LH; Ohno T; Oboki K; Kajiwara N; Suto H; Iikura M; Okayama Y; Akira S; Saito H; Galli SJ; Nakae S
    J Leukoc Biol; 2007 Dec; 82(6):1481-90. PubMed ID: 17881510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α-Dependent miR-155 Suppression.
    Abebayehu D; Spence AJ; Qayum AA; Taruselli MT; McLeod JJ; Caslin HL; Chumanevich AP; Kolawole EM; Paranjape A; Baker B; Ndaw VS; Barnstein BO; Oskeritzian CA; Sell SA; Ryan JJ
    J Immunol; 2016 Oct; 197(7):2909-17. PubMed ID: 27559047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
    Hong GU; Park BS; Park JW; Kim SY; Ro JY
    Cell Signal; 2013 Jun; 25(6):1514-25. PubMed ID: 23524335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.
    Cook GJ; Caudell DL; Elford HL; Pardee TS
    PLoS One; 2014; 9(11):e112619. PubMed ID: 25402485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation.
    Wu Z; Li Y; MacNeil AJ; Junkins RD; Berman JN; Lin TJ
    J Immunol; 2013 Dec; 191(12):5885-94. PubMed ID: 24218457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3(+)-Treg cells enhanced by repeated low-dose gamma-irradiation attenuate ovalbumin-induced allergic asthma in mice.
    Park BS; Hong GU; Ro JY
    Radiat Res; 2013 May; 179(5):570-83. PubMed ID: 23560633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function.
    Nigo YI; Yamashita M; Hirahara K; Shinnakasu R; Inami M; Kimura M; Hasegawa A; Kohno Y; Nakayama T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2286-91. PubMed ID: 16461458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of Trichostatin A on activation of mast cells by different stimulants.
    Wang QH; Nishiyama C; Nakano N; Kanada S; Hara M; Kitamura N; Shimokawa N; Lu CL; Ogawa H; Okumura K
    FEBS Lett; 2010 Jun; 584(11):2315-20. PubMed ID: 20371366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tonggyu-tang, a traditional Korean medicine, suppresses pro-inflammatory cytokine production through inhibition of MAPK and NF-κB activation in human mast cells and keratinocytes.
    Kim HI; Hong SH; Ku JM; Kang S; Kim TY; Shin YC; Ko SG
    BMC Complement Altern Med; 2017 Mar; 17(1):186. PubMed ID: 28359265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.